Erritzoe D.
Ashok A.H.
Searle G.E.
Colasanti A.
Turton S.
Lewis Y.
et al. Serotonin release measured in the human brain: a PET study with [(11)C]CIMBI-36 and d-amphetamine challenge. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 45 : 804-810 View in Article Scopus (13)
PubMed
Crossref
Google Scholar
Gartlehner G.
Hansen R.A.
Morgan L.C.
Thaler K.
Lux L.
Van Noord M.
et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of internal medicine. 155 : 772-785 View in Article Scopus (254)
PubMed
Crossref
Google Scholar
Gaynes B.N.
Warden D.
Trivedi M.H.
Wisniewski S.R.
Fava M.
Rush A.J. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric services. 60 : 1439-1445 View in Article Scopus (415)
PubMed
Crossref
Google Scholar
Delgado P.L. Monoamine depletion studies: implications for antidepressant discontinuation syndrome. The Journal of clinical psychiatry. 67 : 22-26 View in Article PubMed
Google Scholar
Artigas F.
Nutt D.J.
Shelton R. Mechanism of action of antidepressants. Psychopharmacol Bull. 36 : 123-132 View in Article PubMed
Google Scholar
Shopsin B.
Gershon S.
Goldstein M.
Friedman E.
Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacology communications. 1 : 239-249 View in Article PubMed
Google Scholar
Ruhe H.G.
Mason N.S.
Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular psychiatry. 12 : 331-359 View in Article Scopus (549)
PubMed
Crossref
Google Scholar
Dan R.
Ruzicka F.
Bezdicek O.
Ruzicka E.
Roth J.
Vymazal J.
et al. Separate neural representations of depression, anxiety and apathy in Parkinson's disease. Scientific reports. 7 12164 View in Article Scopus (34)
Crossref
Google Scholar
Braak H.
Del Tredici K.
Rub U.
de Vos R.A.
Jansen Steur E.N.
Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of aging. 24 : 197-211 View in Article Scopus (6944)
PubMed
Crossref
Google Scholar
Jorgensen L.M.
Henriksen T.
Mardosiene S.
Keller S.H.
Stenbaek D.S.
Hansen H.D.
et al. Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 41 : 1954-1963 View in Article Scopus (7)
PubMed
Crossref
Google Scholar
Moncrieff J.
Cooper R.E.
Stockmann T.
Amendola S.
Hengartner M.P.
Horowitz M.A. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular psychiatry. View in Article PubMed
Crossref
Google Scholar
Jorgensen L.M.
Weikop P.
Villadsen J.
Visnapuu T.
Ettrup A.
Hansen H.D.
et al. Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. View in Article PubMed
Google Scholar
Shotbolt P.
Tziortzi A.C.
Searle G.E.
Colasanti A.
van der Aart J.
Abanades S.
et al. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 32 : 127-136 View in Article Scopus (106)
PubMed
Crossref
Google Scholar
Erritzoe D. CA, Searle G., Lewis Y., Passchier J., Azeem S., Beaver J., Nutt D., Knudsen G., Gunn R., Rabiner E. (2017): Serotonin release measured in the human brain: A PET study with [11C]Cimbi-36 and d-amphetamine challenge. BrainPET 2017. Berlin, Germany. View in Article Google Scholar
Heal D.J.
Cheetham S.C.
Prow M.R.
Martin K.F.
Buckett W.R. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. British journal of pharmacology. 125 : 301-308 View in Article Scopus (89)
PubMed
Crossref
Google Scholar
Kuczenski R.
Segal D.S.
Cho A.K.
Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. The Journal of neuroscience : the official journal of the Society for Neuroscience. 15 : 1308-1317 View in Article PubMed
Crossref
Google Scholar
Yang K.C.
Takano A.
Halldin C.
Farde L.
Finnema S.J. Serotonin concentration enhancers at clinically relevant doses reduce [(11)C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain. Translational psychiatry. 8 : 132 View in Article Scopus (10)
PubMed
Crossref
Google Scholar
Kehr J.
Ichinose F.
Yoshitake S.
Goiny M.
Sievertsson T.
Nyberg F.
et al. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. British journal of pharmacology. 164 : 1949-1958 View in Article Scopus (220)
PubMed
Crossref
Google Scholar
Nejati V.
Majdi R.
Salehinejad M.A.
Nitsche M.A. The role of dorsolateral and ventromedial prefrontal cortex in the processing of emotional dimensions. Scientific reports. 11 : 1971 View in Article Scopus (31)
PubMed
Crossref
Google Scholar
Ichise M.
Toyama H.
Innis R.B.
Carson R.E. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 22 : 1271-1281 View in Article PubMed
Crossref
Google Scholar
Beliveau V.
Ganz M.
Feng L.
Ozenne B.
Hojgaard L.
Fisher P.M.
et al. A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System. The Journal of neuroscience : the official journal of the Society for Neuroscience. 37 : 120-128 View in Article Scopus (162)
PubMed
Crossref
Google Scholar
Ettrup A.
Svarer C.
McMahon B.
da Cunha-Bang S.
Lehel S.
Moller K.
et al. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. NeuroImage. 130 : 167-174 View in Article Scopus (42)
PubMed
Crossref
Google Scholar
Toll L.
Berzetei-Gurske I.P.
Polgar W.E.
Brandt S.R.
Adapa I.D.
Rodriguez L.
et al. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA research monograph. 178 : 440-466 View in Article PubMed
Google Scholar
Ettrup A.
Hansen M.
Santini M.A.
Paine J.
Gillings N.
Palner M.
et al. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. European journal of nuclear medicine and molecular imaging. 38 : 681-693 View in Article Scopus (101)
PubMed
Crossref
Google Scholar
Johnson S, Stockmeier CA, Meyer JH, Austin MC, Albert PR, Wang J, et al. (2011): The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 36:2139-2148. View in Article Google Scholar
Meyer J.H.
Wilson A.A.
Sagrati S.
Miler L.
Rusjan P.
Bloomfield P.M.
et al. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Archives of general psychiatry. 66 : 1304-1312 View in Article Scopus (140)
PubMed
Crossref
Google Scholar
Meyer J.H.
Ginovart N.
Boovariwala A.
Sagrati S.
Hussey D.
Garcia A.
et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Archives of general psychiatry. 63 : 1209-1216 View in Article Scopus (438)
PubMed
Crossref
Google Scholar
Fukui M.
Rodriguiz R.M.
Zhou J.
Jiang S.X.
Phillips L.E.
Caron M.G.
et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 : 10520-10529 View in Article Scopus (112)
PubMed
Crossref
Google Scholar
Taylor T.N.
Caudle W.M.
Shepherd K.R.
Noorian A.
Jackson C.R.
Iuvone P.M.
et al. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of neuroscience : the official journal of the Society for Neuroscience. 29 : 8103-8113 View in Article Scopus (192)
PubMed
Crossref
Google Scholar
Narboux-Neme N.
Sagne C.
Doly S.
Diaz S.L.
Martin C.B.
Angenard G.
et al. Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 36 : 2538-2550 View in Article Scopus (57)
PubMed
Crossref
Google Scholar
Bhagwagar Z.
Rabiner E.A.
Sargent P.A.
Grasby P.M.
Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular psychiatry. 9 : 386-392 View in Article Scopus (219)
PubMed
Crossref
Google Scholar
Ballanger B.
Klinger H.
Eche J.
Lerond J.
Vallet A.E.
Le Bars D.
et al. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 27 : 84-89 View in Article Scopus (89)
PubMed
Crossref
Google Scholar
Erritzoe D.
Holst K.
Frokjaer V.G.
Licht C.L.
Kalbitzer J.
Nielsen F.A.
et al. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. The Journal of neuroscience : the official journal of the Society for Neuroscience. 30 : 3391-3397 View in Article Scopus (45)
PubMed
Crossref
Google Scholar
Meyer J.H.
McMain S.
Kennedy S.H.
Korman L.
Brown G.M.
DaSilva J.N.
et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. The American journal of psychiatry. 160 : 90-99 View in Article Scopus (217)
PubMed
Crossref
Google Scholar
Bhagwagar Z.
Hinz R.
Taylor M.
Fancy S.
Cowen P.
Grasby P. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. The American journal of psychiatry. 163 : 1580-1587 View in Article Scopus (0)
PubMed
Crossref
Google Scholar
Biver F.
Wikler D.
Lotstra F.
Damhaut P.
Goldman S.
Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. The British journal of psychiatry : the journal of mental science. 171 : 444-448 View in Article Scopus (189)
PubMed
Crossref
Google Scholar
Yatham L.N.
Liddle P.F.
Shiah I.S.
Scarrow G.
Lam R.W.
Adam M.J.
et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Archives of general psychiatry. 57 : 850-858 View in Article Scopus (163)
PubMed
Crossref
Google Scholar
Messa C.
Colombo C.
Moresco R.M.
Gobbo C.
Galli L.
Lucignani G.
et al. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology. 167 : 72-78 View in Article Scopus (90)
PubMed
Crossref
Google Scholar
Meyer J.H.
Kapur S.
Houle S.
DaSilva J.
Owczarek B.
Brown G.M.
et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. The American journal of psychiatry. 156 : 1029-1034 View in Article PubMed
Crossref
Google Scholar
Frokjaer V.G.
Vinberg M.
Erritzoe D.
Baare W.
Holst K.K.
Mortensen E.L.
et al. Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 35 : 1129-1137 View in Article Scopus (43)
PubMed
Crossref
Google Scholar
Meyer J.H.
Kapur S.
Eisfeld B.
Brown G.M.
Houle S.
DaSilva J.
et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. The American journal of psychiatry. 158 : 78-85 View in Article Scopus (199)
PubMed
Crossref
Google Scholar
Narendran R.
Slifstein M.
Guillin O.
Hwang Y.
Hwang D.R.
Scher E.
et al. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse. 60 : 485-495 View in Article Scopus (148)
PubMed
Crossref
Google Scholar
Cumming P.
Wong D.F.
Gillings N.
Hilton J.
Scheffel U.
Gjedde A. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 22 : 596-604 View in Article Scopus (68)
PubMed
Crossref
Google Scholar
Leonhardt S.
Gorospe E.
Hoffman B.J.
Teitler M. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. Molecular pharmacology. 42 : 328-335 View in Article PubMed
Google Scholar
Teitler M.
Leonhardt S.
Weisberg E.L.
Hoffman B.J. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes. Molecular pharmacology. 38 : 594-598 View in Article PubMed
Google Scholar